Home MarketAlbert David Ltd.

Albert David Ltd. Stock Info: As on 2017-09-22 15:51:30

Nse

287.80

-4.70(-1.61%)
Change%
52 Week Range
275.00
30.00
425.00
25.00
Open295.00
Day's Range234.00 - 351.00
Value Traded (in ₹ Cr.) 0.09

Bse

288.95

-3.25(-1.11%)
Change %
52 Week Range
280.00
30.00
424.80
25.00
Open296.45
Day's Range233.76 - 350.64
Value Traded (in ₹ Cr.) 0.06

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 3,475,514.00 60.90%
Mutual Funds/UTI 900.00 0.02%
FII 0.00 0.00%
Employee 0.00 0.00%
Public 1,682,216.00 29.48%
Government 0.00 0.00%
Others 287,989.00 5.05%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 0.52
Basic EPS (Rs.) 84.10
Cash EPS 99.86
BVPerShare Excl 239.75
Operating Revenue 564.53
PBDITPerShare 57.86
Dividend 5.50
NPPerShare 84.10
Current Ratio 2.01
Quick Ratio 1.37
PriceToBV 1.25
Earnings 0.28
PBDIT Margin 10.24
PBT Margin 19.55
NP Margin 14.89
Return On Assets 21.44
Retention Ratios 93.45
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 324.16
Total Expenses 301.94
EBITDA 33.02
PBT 63.02
PAT 48.00
Net Income 48.00
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 143.76
Total Expenses 136.50
EBITDA 2.69
PBT 47.32
PAT 38.83
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 5.71
Net worth 136.83
Investments 47.54
Total Liability 223.84
Total debt 20.23
Net block 49.45
Total Assets 223.84
Parameter Sep-16 (₹ Cr.) 6M % change
Total share capital 5.71
Net worth 102.01
Investments 16.50
Total Liability 198.80
Total debt 21.19
Net block 51.38
Total Assets 198.80
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

526.85 535.6 -1.63
526544.45

Abbott India Ltd.

4252.9 4252.25 0.02
40014264

Ajanta Pharma Ltd.

1208.5 1256.6 -3.83
11881265

Alembic Ltd.

40.2 43.1 -6.73
38.1544.7

Alembic Pharmaceuticals Ltd.

489.95 500.35 -2.08
469.85504

Alkem Laboratories Ltd.

1800.95 1801.2 -0.01
17341819

Alpa Laboratories Ltd.

31.7 30.2 4.97
27.8530.2
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

103.15 101.05 2.08
90121.9

Aarti Drugs Ltd.

524.5 533.85 -1.75
525540

Aayush Food & Herbs Ltd.

48.55 48.55 0
48.5548.55

Abbott India Ltd.

4164 4269.8 -2.48
40354275

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities 68.21
Cash from investing activities -38.34
Cash from financing activities -17.93
Net change in cash 11.95

Stock Held By Mutual Fund Schemes

SAIL eyes higher market share on surging steel demand: Chairman

Armed with latest technologies and higher product mix, SAIL aims to tap big into the steel demand in India, which is projected to become the fifth- largest economy this year, its Chairman P K Singh said. Addressing the 45th annual general meeting of the state- owned Steel Authority of India Ltd (SAIL) here, Singh said the steel demand in India will witness a significant growth in future, given the current stage of development in Indian economy. The World Steel Association, in its short range outlook, has forecast 6.1 per cent growth in steel consumption for India in 2017, the SAIL chief added. According to Singh, the domestic steel demand is improving on the back of government policies and developmental goals, and SAIL is expeditiously equipping itself to serve market requirements fully and claim a broader market share. SAIL with newer and better technologies at its disposal aims to leverage potential of growth in steel demand by operating at rated capacities, product differentiation and customer satisfaction, Singh said. The chairman also shared the company's efforts towards product value addition. SAIL has done significant value addition in its product mix, with higher grades of steel... from Rourkela Steel Plant's new plate mill for the oil and gas sector, SAIL HT-600 for the automotive sector and high strength LPG steel grade from Bokaro Steel Plant, etc, Singh said. At Bhilai Steel Plant (BSP), the world's longest single piece rail of 130 metres is being produced and supplies of welded 260 metres rail panels to the Indian Railways are in progress. Besides, a 3 mtpa hot strip mill in Rourkela is slated to be installed by 2018. He further said, World economic recovery is on track... and presents a healthy sign for industrial and manufacturing activities across globe. India is projected to become the world's fifth-largest economy in 2017, surpassing UK and France and the world's third largest economy by 2023, surpassing Japan and Germany. Such kind of growth will definitely create larger steel demand and boost consumption in country, the chairman added. Listing out the achievements of SAIL, Singh said the company since inception has produced 475 million tonnes (mt) of crude steel and partnered in all major national projects requiring steel. The company is also taking initiatives towards remodelling its operations.

22-09-2017 16:49

PNB plans to raise up to Rs 5000 cr from markets

Punjab National Bank today said it plans to raise up to Rs 5,000 crore equity capital from the markets to fund growth. The public sector bank however did not give any indication as to whether it would be raised by diluting government equity or issuing Additional Tier-1 (AT1) bonds. The decision in this regard would be taken in the board meeting on September 27, PNB said in a filing to the stock exchanges. The bank would consider raising common equity Tier capital up to Rs 5,000 crore as per Basel III requirements, it said. PNB had reported over 12 per cent rise in net profit at Rs 343.40 crore for the quarter ended June 30, 2017. Total income of the bank rose to Rs 14,468.14 crore in the said quarter from Rs 13,475.41 crore a year ago. With regard to assets metrics, the bank's gross non- performing assets (NPAs) declined marginally to 13.66 per cent of gross advances as on June 30, 2017 from 13.75 per cent a year ago. Meanwhile, shares of the Bank closed trading at Rs 137.80 apiece, down 2.92 per cent from the previous close on BSE.

22-09-2017 15:47

SBI's new index at LSE to help investors track Indian bonds

State Bank of India, in partnership with FTSE Russell, brought out a new index series at the London Stock Exchange to enable investors and market participants to track Indian bond movement. FTSE Russell is a global data and analytics provider. The FTSE SBI Bond Index Series demonstrates SBI's commitment to play befitting leadership role in development of India's bond market, State Bank of India (SBI) said in a statement. We have teamed up with FTSE Russell to launch the FTSE- SBI Bond Index Series. This index will act as a key benchmark for Indian debt for foreign investors looking to invest in Indian debt market, SBI Chairman Arundhati Bhattacharya said in the statement. It will significantly contribute to development and broadening of the Indian bond market, Bhattacharya hoped. The index series, SBI said, provides the global investor community and other market participants the tools they need to analyse India's bond market. The launch follows the November 2015 visit of Prime Minister Narendra Modi in the UK when a letter of intent was singed between SBI and FTSE to jointly develop the new index tracking Indian fixed income securities. This initiative was also announced as a priority under the India UK Financial Partnership (IUKFP), SBI said further. Today's launch of this innovative index series demonstrates SBI's commitment to play befitting leadership role in development of India's bond market. This index is also an important enabler of India-focused funds and is expected to facilitate investment flows, the bank said. Meanwhile, shares of the Bank closed trading at Rs 261.90 apiece, down 2.46 per cent from the previous close on BSE.

22-09-2017 15:44

Adhunik Industries hits 52 week low on SAT order

Shares of Adhunik Industries plunged 20 per cent, hitting 52-week low, on the Bombay Stock Exchange after the Securities Appellate Tribunal (SAT) directed the market regulator to reverse their decisions all dated August 7, 2017 qua the appellant forthwith. According to data available with exchange, as much as 792 lakh shares changed hands over-the-counter as compared to two week average of 1.54 lakhs. Weighed down by the development, shares of the company declined as much as 20 per cent to hit 52-week low of Rs 83.55 apiece on the Bombay Stock Exchange. The stocks were currently trading at Rs 83.55 against previous close price of Rs 104.40. In a similar fashion, shares of the company were trading 19.98 per cent lower at Rs 79.10 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 31,944.47, down 425.57 points, or 1.30 per cent, at 14:45 hours.

22-09-2017 14:57

Dabur India joins hand with Amazon for ayurveda marketplace

Homegrown FMCG major Dabur India today said it has tied up with e-commerce major Amazon for an online ayurveda marketplace which will house all ayurvedic brands and products available in the country. The company, which will also offer consumers an insight into various ayurvedic medicines for treating a variety of ailments, said the idea is to service all health and personal care related needs of patients. The exclusive ayurveda e-marketplace has been hosted by Amazon India and the content is developed by Dabur India, the company said in a statement. Consumers can search basis companies, brands and ailments and will gain access to all ayurveda solutions available in the country today, Dabur India Executive Director Consumer Care Business KK Chutani said. Products of other ayurvedic manufacturing companies like Baba Ramdev-promoted Patanjali and Himalaya would also feature on the marketplace. By providing A+ content for developing this marketplace, Dabur also gains prime visibility on the portal, Chutani said. Meanwhile, shares of the company were trading at Rs 305.70 apiece, down 1.51 per cent from the previous close at 14:50 hours on BSE.

22-09-2017 14:48

Albert David Ltd - Updates

Trading window open from 16th September, 2017

16-Sep-2017 10:52 AM

Albert David Ltd - Trading Window

Albert David Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

16-Sep-2017 10:45 AM

Albert David Ltd - Shareholders meeting

Albert David Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 12, 2017. Further, the company has informed the Exchange regarding voting results.

13-Sep-2017 07:14 PM

Albert David Ltd - Scrutinizer's Report

Submission of Scrutinizer's Report and the Voting Result in prescribed format pursuant to Regulation 44 of the Listing Regulations of 78th Annual General Meeting of the Company.

13-Sep-2017 06:58 PM

Albert David Ltd - Press Release

Albert David Limited has informed the Exchange regarding a press release dated September 13, 2017, titled Extract of Un-audited Financial Results for the Qtr. Ended 30th June, 2017.

13-Sep-2017 05:26 PM

Albert David Ltd - Updates

Trading window open from 16th September, 2017

16-Sep-2017 10:52 AM

Albert David Ltd - Scrutinizer's Report

Submission of Scrutinizer's Report and the Voting Result in prescribed format pursuant to Regulation 44 of the Listing Regulations of 78th Annual General Meeting of the Company.

13-Sep-2017 06:58 PM

Albert David Ltd - Newspaper Publication

Publication of extract of Un-audited Financial Results of the Company for the qtr. ended 30-6-2017.

13-Sep-2017 05:12 PM

Corporate Details

About Management

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Registered Office

D - Block, 3rd Floor, Gillander House, Netaji Subhas Road,

033-22302330,22628436,22628456-8492,      033-22258714,

adidavid@dataone.in

http://www.albertdavidindia.com

Registrar Details

Maheshwari Datamatics (P) Ltd.